Target intelligence / Profile preview

Fusobacterium necrophorum leukotoxin (Lkt) (Lkt)

Target
Lkt
Molecular classification
Bacterial exotoxin, Pore-forming toxin, Virulence factor
01

Overview

Fusobacterium necrophorum leukotoxin (Lkt) is a high-molecular-weight extracellular protein and the primary virulence factor of the anaerobic bacterium Fusobacterium necrophorum (Narayanan et al., 2002). It is a potent exotoxin that specifically targets and destroys host leukocytes, including neutrophils and macrophages, thereby impairing the host's primary immune defense (Tadepalli et al., 2009). In cattle, Lkt is the central driver in the development of hepatic abscesses and foot rot, leading to significant economic losses in the livestock industry (Nagaraja & Chengappa, 1998). In humans, the toxin is implicated in the pathogenesis of Lemierre's syndrome, where it facilitates the spread of infection from the oropharynx to the internal jugular vein (Riordan, 2007). The molecular mechanism involves the formation of pores in the target cell membrane, which results in osmotic lysis at high concentrations or the induction of apoptosis at lower concentrations (Narayanan et al., 2002). Because of its critical role in disease, Lkt is a major target for veterinary vaccine development, specifically in the form of toxoid-based formulations that stimulate the production of neutralizing antibodies (Nagaraja et al., 2005). While clinical management of human infections currently relies on antibiotics to eliminate the source bacteria, Lkt remains a significant target for potential adjunctive antitoxin therapies to reduce tissue damage.

Other names
Leukotoxin ALktAF. necrophorum exotoxinNecrobacillosis toxin
02

Mechanism of action

The leukotoxin acts by binding to the host cell membrane and forming pores, which leads to an influx of ions and water, resulting in cell swelling and osmotic lysis (necrosis) at high concentrations, or triggering apoptotic pathways at lower concentrations (Narayanan et al., 2002).

03

Biological functions

ApoptosisCell deathImmune responseCytolysisLeukocyte killing
04

Disease associations

InfectionInflammationLemierre's syndromeBovine liver abscessFoot rot
05

Safety considerations

High toxicity to host immune cellsPotential for systemic inflammatory response during infectionSpecies-specific activity levels
06

Interacting drugs

Fusobacterium necrophorum toxoid vaccine
07

Biomarkers

Anti-leukotoxin antibody titer

Beyond the preview

Go deeper on Fusobacterium necrophorum leukotoxin (Lkt) (Lkt).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fusobacterium necrophorum leukotoxin (Lkt) (Lkt).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call